Back
Global X Artfcl Intlgc & Tech ETF Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
67
AIQ
Global X Artfcl Intlgc & Tech ETF
Last Price:
37.23
Seasonality Move:
2.74%
Sell
45
MIRM
Mirum Pharmaceuticals
Last Price:
38.87
Seasonality Move:
5.99%
Buy
67
Global X Artfcl Intlgc & Tech ETF (AIQ)
is a Buy
Is Global X Artfcl Intlgc & Tech ETF a Buy, Sell or Hold?
- The current Global X Artfcl Intlgc & Tech ETF [AIQ] share price is $37.32. The Score for AIQ is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- AIQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $38.72. The Score for MIRM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AIQ Stock Price Chart
What is Global X Artfcl Intlgc & Tech ETF's stock price today?
-
The Global X Artfcl Intlgc & Tech ETF share price today is $37.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AIQ is experiencing slight buying pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $38.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight selling pressure.
AIQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 70.2 | Buy |
| Chaikin Money Flow: | 148048 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.24 - 36.06) | Buy |
| Bollinger Bands (100): | (33.69 - 35.99) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 41.61 | Sell |
| Chaikin Money Flow: | -57139 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.33 - 42.57) | Sell |
| Bollinger Bands (100): | (28.23 - 41.85) | Buy |
AIQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.09 | Buy |
| 20-day SMA: | 35.14 | Buy |
| 50-day SMA: | 34.69 | Buy |
| 200-day SMA: | 33.6 | Buy |
| 8-day EMA: | 36.23 | Buy |
| 20-day EMA: | 35.52 | Buy |
| 50-day EMA: | 35.05 | Buy |
| 200-day EMA: | 33.26 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.01 | Sell |
| 20-day SMA: | 40.52 | Sell |
| 50-day SMA: | 40.71 | Sell |
| 200-day SMA: | 31.23 | Buy |
| 8-day EMA: | 39.24 | Sell |
| 20-day EMA: | 40.05 | Sell |
| 50-day EMA: | 39.32 | Sell |
| 200-day EMA: | 33.16 | Buy |
Global X Artfcl Intlgc & Tech ETF Earnings Growth & AIQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Global X Artfcl Intlgc & Tech ETF Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||